Several countries have also seen such declines in disease in older children and adults but such data from developing country settings in more limited. Many countries have shown substantial diversity in circulating strains as has been

seen in India and available vaccines have been shown to provide heterotypic protection against a wide range of genotypes. Risk benefit analyses have shown that rotavirus vaccine benefits greatly outweigh risk especially in high disease burden settings like India. With the potential availability of multiple indigenously selleck kinase inhibitor manufactured rotavirus vaccines in the next few years, Indian policy-makers will need to weigh available local data on disease and economic burden with cost-effectiveness, safety, and efficacy of the vaccines in their decision to introduce rotavirus vaccines into the national immunization program. This supplement contains up-to-date data on these issues, highlighting the tremendous health and economic burden of rotavirus in this website Indian children, the lack of any safety signals in clinical testing so far and underscoring the potential value of vaccination. While a wide diversity

of circulating rotavirus strains in Indian children was noted, it is reassuring from both global data and from clinical trial data for 116E that rotavirus PD184352 (CI-1040) vaccines provide good protection against a range of circulating strains, including those that are not included in the vaccines. Nevertheless, on-going surveillance for rotavirus gastroenteritis through the Indian Rotavirus Surveillance System will continue to provide valuable information about rotavirus disease burden and strain diversity in India, and should provide a valuable platform to assess the large anticipated health benefits of vaccination. None. “
“In public health, success in controlling,

eliminating, or eradicating a disease depends on availability of good quality surveillance data at the national level. A problem cannot be addressed until it is measured systematically. With regard to the vaccine-preventable diseases, surveillance activities are critical to detect and reliably measure to provide data to define the epidemiology of a disease, identify circulating strains or serotypes/genotypes, monitor disease trends and to assess whether an intervention such as a vaccine is necessary. If a decision to introduce vaccine is to be made then there is need to have continued surveillance to demonstrate effectiveness, and efficacy of vaccine against various strains or different disease severity, to demonstrate a decrease in vaccine preventable disease in vaccinated individuals as well as to know whether there is any herd immunity [1], [2] and [3].